Skip to main content
SpringerLink
Log in

No evidence for increased tumor rates below 200 mSv in the atomic bomb survivors data

  • CONTROVERSIAL ISSUE
  • Published:
Radiation and Environmental Biophysics Aims and scope Submit manuscript

Abstract

We investigated for which doses a significantly increased tumor rate can be seen in the RERF Life Span Study data sets on mortality or incidence of solid tumors. No significant increase was found below about 200 mSv.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. GSF – National Research Center for Environment and Health, Institute of Radiation Protection, D-85758 Neuherberg, Germany, , , , , , DE

    W. F. Heidenreich, H. G. Paretzke & P. Jacob

Authors
  1. W. F. Heidenreich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. G. Paretzke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 28 April 1997 / Accepted in revised form: 2 June 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heidenreich, W., Paretzke, H. & Jacob, P. No evidence for increased tumor rates below 200 mSv in the atomic bomb survivors data. Radiat Environ Biophys 36, 205–207 (1997). https://doi.org/10.1007/s004110050073

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004110050073

Keywords

Search

Navigation